Reference |
---|
Bai P, Liu Y, Xue S, Hamri G, Saxena P, Ye H, et al. A fully human transgene switch to regulate therapeutic protein production by cooling sensation. Nat Med. 2019;25:1266-1273 pubmed publisher
|
Sahoo S, Singh P, Kalha B, Singh O, Pal R. Gonadotropin-mediated chemoresistance: Delineation of molecular pathways and targets. BMC Cancer. 2015;15:931 pubmed publisher
|
Knight J, Mak G, Shaw J, Porter P, McDermott C, Roberts L, et al. Long-Acting Beta Agonists Enhance Allergic Airway Disease. PLoS ONE. 2015;10:e0142212 pubmed publisher
|
Ranganath S, Bhandari A, Avitahl Curtis N, McMahon J, Wachtel D, Zhang J, et al. Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo. PLoS ONE. 2015;10:e0141330 pubmed publisher
|
Castellana B, Aasen T, Moreno Bueno G, Dunn S, Ramón y Cajal S. Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells. Oncotarget. 2015;6:38239-56 pubmed publisher
|
de Mattos Arruda L, Bottai G, Nuciforo P, Di Tommaso L, Giovannetti E, Peg V, et al. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. Oncotarget. 2015;6:37269-80 pubmed publisher
|
Wienke J, Janssen W, Scholman R, Spits H, van Gijn M, Boes M, et al. A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation. Oncotarget. 2015;6:20037-42 pubmed
|
Lin W, Yi Z, Stunz L, Maine C, Sherman L, Bishop G. The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development. Sci Signal. 2015;8:ra88 pubmed publisher
|
Liu R, Li X, Zhang Z, Zhou M, Sun Y, Su D, et al. Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis. Sci Rep. 2015;5:12777 pubmed publisher
|
Dong B, Shi Z, Wang J, Wu J, Yang Z, Fang K. IL-6 Inhibits the Targeted Modulation of PDCD4 by miR-21 in Prostate Cancer. PLoS ONE. 2015;10:e0134366 pubmed publisher
|
Huang R, Chen G, Wang W, Herller T, Xie Y, Gu B, et al. Synergy between IL-6 and soluble IL-6 receptor enhances bone morphogenetic protein-2/absorbable collagen sponge-induced bone regeneration via regulation of BMPRIA distribution and degradation. Biomaterials. 2015;67:308-22 pubmed publisher
|
Lissat A, Joerschke M, Shinde D, Braunschweig T, Meier A, Makowska A, et al. IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells. BMC Cancer. 2015;15:552 pubmed publisher
|
Patel S, Gooderham N. IL6 Mediates Immune and Colorectal Cancer Cell Cross-talk via miR-21 and miR-29b. Mol Cancer Res. 2015;13:1502-8 pubmed publisher
|
Fujimoto K, Ida H, Hirota Y, Ishigai M, Amano J, Tanaka Y. Intracellular Dynamics and Fate of a Humanized Anti-Interleukin-6 Receptor Monoclonal Antibody, Tocilizumab. Mol Pharmacol. 2015;88:660-75 pubmed publisher
|
Ma S, Zhuang Q, Shen W, Peng Y, Qiu Y. Interleukin-6 reduces NMDAR-mediated cytosolic Ca²⺠overload and neuronal death via JAK/CaN signaling. Cell Calcium. 2015;58:286-95 pubmed publisher
|
Lu X, Luo F, Liu Y, Zhang A, Li J, Wang B, et al. The IL-6/STAT3 pathway via miR-21 is involved in the neoplastic and metastatic properties of arsenite-transformed human keratinocytes. Toxicol Lett. 2015;237:191-9 pubmed publisher
|
Xue Q, Lu Y, Eisele M, Sulistijo E, Khan N, Fan R, et al. Analysis of single-cell cytokine secretion reveals a role for paracrine signaling in coordinating macrophage responses to TLR4 stimulation. Sci Signal. 2015;8:ra59 pubmed publisher
|
Kawano A, Kadomatsu R, Ono M, Kojima S, Tsukimoto M, Sakamoto H. Autocrine Regulation of UVA-Induced IL-6 Production via Release of ATP and Activation of P2Y Receptors. PLoS ONE. 2015;10:e0127919 pubmed publisher
|
Minichsdorfer C, Wasinger C, Sieczkowski E, Atil B, Hohenegger M. Tocilizumab unmasks a stage-dependent interleukin-6 component in statin-induced apoptosis of metastatic melanoma cells. Melanoma Res. 2015;25:284-94 pubmed publisher
|
Relja B, Omid N, Schaible A, Perl M, Meier S, Oppermann E, et al. Pre- or post-treatment with ethanol and ethyl pyruvate results in distinct anti-inflammatory responses of human lung epithelial cells triggered by interleukin-6. Mol Med Rep. 2015;12:2991-8 pubmed publisher
|
Borowiec A, Kontny E, Smolis Bąk E, Kowalik I, Majos E, Załucka L, et al. Prospective assessment of cytokine IL-15 activity in patients with refractory atrial fibrillation episodes. Cytokine. 2015;74:164-70 pubmed publisher
|
Schütz A, Röser K, Klitzsch J, Lieder F, Aberger F, Gruber W, et al. Lung Adenocarcinomas and Lung Cancer Cell Lines Show Association of MMP-1 Expression With STAT3 Activation. Transl Oncol. 2015;8:97-105 pubmed publisher
|
Li P, Shan J, Chen X, Zhang D, Su L, Huang X, et al. Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment. Cell Res. 2015;25:588-603 pubmed publisher
|
Chen Q, Zhao M, Guo F, Yin Y, Xiao J, Stone P, et al. The reduction of circulating levels of IL-6 in pregnant women with preeclampsia by magnesium sulphate and nifedipine: In vitro evidence for potential mechanisms. Placenta. 2015;36:661-6 pubmed publisher
|
Stubbington M, Mahata B, Svensson V, Deonarine A, Nissen J, Betz A, et al. An atlas of mouse CD4(+) T cell transcriptomes. Biol Direct. 2015;10:14 pubmed publisher
|
Simamura E, Arikawa T, Ikeda T, Shimada H, Shoji H, Masuta H, et al. Melanocortins contribute to sequential differentiation and enucleation of human erythroblasts via melanocortin receptors 1, 2 and 5. PLoS ONE. 2015;10:e0123232 pubmed publisher
|
Kajita A, Morizane S, Takiguchi T, Yamamoto T, Yamada M, Iwatsuki K. Interferon-Gamma Enhances TLR3 Expression and Anti-Viral Activity in Keratinocytes. J Invest Dermatol. 2015;135:2005-2011 pubmed publisher
|
Joo M, Park J, Kim S, Yoo H, Lee B, Chun H, et al. Antitumorigenic effect of plumbagin by induction of SH2-containing protein tyrosine phosphatase 1 in human gastric cancer cells. Int J Oncol. 2015;46:2380-8 pubmed publisher
|
Siwetz M, Dieber Rotheneder M, Cervar Zivkovic M, Kummer D, Kremshofer J, Weiss G, et al. Placental fractalkine is up-regulated in severe early-onset preeclampsia. Am J Pathol. 2015;185:1334-43 pubmed publisher
|
Bouezzedine F, Fardel O, Gripon P. Interleukin 6 inhibits HBV entry through NTCP down regulation. Virology. 2015;481:34-42 pubmed publisher
|
Luo Q, Zhang J, Wang H, Chen F, Luo X, Miao B, et al. Expression and Regulation of Transcription Factor FoxA2 in Chronic Rhinosinusitis With and Without Nasal Polyps. Allergy Asthma Immunol Res. 2015;7:458-66 pubmed publisher
|
Mao F, Xu M, Zuo X, Yu J, Xu W, Moussalli M, et al. 15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway. FASEB J. 2015;29:2359-70 pubmed publisher
|
Nikkheslat N, Zunszain P, Horowitz M, Barbosa I, Parker J, Myint A, et al. Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression. Brain Behav Immun. 2015;48:8-18 pubmed publisher
|
Gritsina G, Xiao F, O Brien S, Gabbasov R, Maglaty M, Xu R, et al. Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth. Mol Cancer Ther. 2015;14:1035-47 pubmed publisher
|
Kawabata H, Uchiyama T, Sakamoto S, Kanda J, Oishi S, Fujii N, et al. A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression. Exp Hematol. 2015;43:404-413.e5 pubmed publisher
|
Kondo M, Yamaoka K, Sakata K, Sonomoto K, Lin L, Nakano K, et al. Contribution of the Interleukin-6/STAT-3 Signaling Pathway to Chondrogenic Differentiation of Human Mesenchymal Stem Cells. Arthritis Rheumatol. 2015;67:1250-60 pubmed publisher
|
Lai C, Moon Y, Kuchenbauer F, Starzcynowski D, Argiropoulos B, Yung E, et al. Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogene. PLoS ONE. 2014;9:e112671 pubmed publisher
|
Kshirsagar S, Riedl M, Billing H, Tönshoff B, Thangavadivel S, Steuber C, et al. Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis. J Immunol. 2014;193:4895-903 pubmed publisher
|
Caiello I, Minnone G, Holzinger D, Vogl T, Prencipe G, Manzo A, et al. IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases. PLoS ONE. 2014;9:e107886 pubmed publisher
|
Wang S, Hu J, Guo Q, Zhao Y, Cheng J, Zhang D, et al. AZD1480, a JAK inhibitor, inhibits cell growth and survival of colorectal cancer via modulating the JAK2/STAT3 signaling pathway. Oncol Rep. 2014;32:1991-8 pubmed publisher
|
Mandai H, Omori K, Yamamoto D, Tsumura T, Murota K, Yamamoto S, et al. Synthetic (+)-terrein suppresses interleukin-6/soluble interleukin-6 receptor induced-secretion of vascular endothelial growth factor in human gingival fibroblasts. Bioorg Med Chem. 2014;22:5338-44 pubmed publisher
|
Kåbjörn Gustafsson C, Ståhlberg A, Engtröm K, Danielsson A, Turesson I, Aman P. Cell senescence in myxoid/round cell liposarcoma. Sarcoma. 2014;2014:208786 pubmed publisher
|
Li C, Xu F, Chow S, Feng L, Yin D, Ng T, et al. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Eur J Cancer. 2014;50:2560-9 pubmed publisher
|
O TOOLE A, Michielsen A, Nolan B, Tosetto M, Sheahan K, Mulcahy H, et al. Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive. Br J Cancer. 2014;111:927-32 pubmed publisher
|
Melemedjian O, Tillu D, Moy J, Asiedu M, Mandell E, Ghosh S, et al. Local translation and retrograde axonal transport of CREB regulates IL-6-induced nociceptive plasticity. Mol Pain. 2014;10:45 pubmed publisher
|
Yan H, Huang X, Ke S, Jiang Y, Zhang Y, Wang Y, et al. Interleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation. Cancer Sci. 2014;105:1220-7 pubmed publisher
|
Zhao Y, Yao J, Wu X, Zhao L, Zhou Y, Zhang Y, et al. Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL-6/STAT3 signaling pathway. Mol Carcinog. 2015;54 Suppl 1:E81-93 pubmed publisher
|
Arranz Valsero I, Soriano Romaní L, García Posadas L, López García A, Diebold Y. IL-6 as a corneal wound healing mediator in an in vitro scratch assay. Exp Eye Res. 2014;125:183-92 pubmed publisher
|
Mimura N, Hideshima T, Shimomura T, Suzuki R, Ohguchi H, Rizq O, et al. Selective and potent Akt inhibition triggers anti-myeloma activities and enhances fatal endoplasmic reticulum stress induced by proteasome inhibition. Cancer Res. 2014;74:4458-69 pubmed publisher
|
Song L, Smith M, Doshi P, Sasser K, Fulp W, Altiok S, et al. Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer. J Thorac Oncol. 2014;9:974-82 pubmed publisher
|
Fischer A, Zelinka C, Gallina D, Scott M, Todd L. Reactive microglia and macrophage facilitate the formation of Müller glia-derived retinal progenitors. Glia. 2014;62:1608-28 pubmed publisher
|
Linher Melville K, Singh G. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells. BMC Cancer. 2014;14:415 pubmed publisher
|
Mace T, King S, Ameen Z, Elnaggar O, Young G, Riedl K, et al. Bioactive compounds or metabolites from black raspberries modulate T lymphocyte proliferation, myeloid cell differentiation and Jak/STAT signaling. Cancer Immunol Immunother. 2014;63:889-900 pubmed publisher
|
Vartoukian S, Tilakaratne W, Seoudi N, Bombardieri M, Bergmeier L, Tappuni A, et al. Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome. Clin Exp Immunol. 2014;177:618-29 pubmed publisher
|
Duek A, Lundberg P, Shimizu T, Grisouard J, Karow A, Kubovcakova L, et al. Loss of Stat1 decreases megakaryopoiesis and favors erythropoiesis in a JAK2-V617F-driven mouse model of MPNs. Blood. 2014;123:3943-50 pubmed publisher
|
Catalli A, Karpov V, Erdos L, Tancowny B, Schleimer R, Kulka M. Stimulus-selective regulation of human mast cell gene expression, degranulation and leukotriene production by fluticasone and salmeterol. PLoS ONE. 2014;9:e96891 pubmed publisher
|
Miao J, Liu L, Huang J. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma. Int J Oncol. 2014;45:165-76 pubmed publisher
|
Jimeno R, Leceta J, Martinez C, Gutierrez Cañas I, Carrión M, Pérez García S, et al. Vasoactive intestinal peptide maintains the nonpathogenic profile of human th17-polarized cells. J Mol Neurosci. 2014;54:512-25 pubmed publisher
|
Abdi J, Mutis T, Garssen J, Redegeld F. Toll-like receptor (TLR)-1/2 triggering of multiple myeloma cells modulates their adhesion to bone marrow stromal cells and enhances bortezomib-induced apoptosis. PLoS ONE. 2014;9:e96608 pubmed publisher
|
Zhao Z, Cheng X, Wang Y, Han R, Li L, Xiang T, et al. Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis. PLoS ONE. 2014;9:e95884 pubmed publisher
|
Cai Y, Yuchi Y, De Groef S, Coppens V, Leuckx G, Baeyens L, et al. IL-6-dependent proliferation of alpha cells in mice with partial pancreatic-duct ligation. Diabetologia. 2014;57:1420-7 pubmed publisher
|
Borsi E, Perrone G, Terragna C, Martello M, Dico A, Solaini G, et al. Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma. Oncotarget. 2014;5:1779-92 pubmed
|
Lee H, Lee M, Bhang S, Kim B, Kim Y, Ju J, et al. Hyaluronate-gold nanoparticle/tocilizumab complex for the treatment of rheumatoid arthritis. ACS Nano. 2014;8:4790-8 pubmed publisher
|
Bu Y, Su F, Wang X, Gao H, Lei L, Chang N, et al. Protein tyrosine phosphatase PTPN9 regulates erythroid cell development through STAT3 dephosphorylation in zebrafish. J Cell Sci. 2014;127:2761-70 pubmed publisher
|
Dehai C, Bo P, Qiang T, Lihua S, Fang L, Shi J, et al. Enhanced invasion of lung adenocarcinoma cells after co-culture with THP-1-derived macrophages via the induction of EMT by IL-6. Immunol Lett. 2014;160:1-10 pubmed publisher
|
Li L, Han R, Xiao H, Lin C, Wang Y, Liu H, et al. Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal. Clin Cancer Res. 2014;20:2714-26 pubmed publisher
|
Seed T, Inal C, Singh V. Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis. Int J Radiat Biol. 2014;90:594-604 pubmed publisher
|
Shive C, Mudd J, Funderburg N, Sieg S, Kyi B, Bazdar D, et al. Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease. J Infect Dis. 2014;210:619-29 pubmed publisher
|
Minashima T, Zhang Y, Lee Y, Kirsch T. Lithium protects against cartilage degradation in osteoarthritis. Arthritis Rheumatol. 2014;66:1228-36 pubmed publisher
|
Imai F, Kishi H, Nakao K, Nishimura T, Minegishi T. IL-6 up-regulates the expression of rat LH receptors during granulosa cell differentiation. Endocrinology. 2014;155:1436-44 pubmed publisher
|
Zhang B, Yin Y, Lai R, Tan S, Choo A, Lim S. Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev. 2014;23:1233-44 pubmed publisher
|
Johnston P, Sen M, Hua Y, Camarco D, Shun T, Lazo J, et al. High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines. Assay Drug Dev Technol. 2014;12:55-79 pubmed publisher
|